Home/Filings/4/0001367644-21-000015
4//SEC Filing

Strei Katherine 4

Accession 0001367644-21-000015

CIK 0001367644other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 9:22 PM ET

Size

6.8 KB

Accession

0001367644-21-000015

Insider Transaction Report

Form 4
Period: 2021-02-09
Strei Katherine
EVP, Chief HR Officer
Transactions
  • Award

    Common Stock

    2021-02-09+2,01430,023 total
  • Tax Payment

    Common Stock

    2021-02-09$123.45/sh2,042$252,08527,981 total
Footnotes (2)
  • [F1]Consists of Performance Stock Units ("PSUs") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 6,043 shares of common stock, which is in excess of the 4,029 shares previously reported on March 1, 2018.
  • [F2]Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs.

Issuer

Emergent BioSolutions Inc.

CIK 0001367644

Entity typeother

Related Parties

1
  • filerCIK 0001709639

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:22 PM ET
Size
6.8 KB